TRANSIENT REDUCTION OF AUTOANTIBODIES AGAINST OXIDIZED LDL IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION

被引：49

作者：

SCHUMACHER, M ^{[1
]}

EBER, B ^{[1
]}

TATZBER, F ^{[1
]}

KAUFMANN, P ^{[1
]}

HALWACHS, G ^{[1
]}

FRUHWALD, FM ^{[1
]}

ZWEIKER, R ^{[1
]}

ESTERBAUER, H ^{[1
]}

KLEIN, W ^{[1
]}

机构：

[1] GRAZ UNIV,INST BIOCHEM,A-8036 GRAZ,AUSTRIA

来源：

FREE RADICAL BIOLOGY AND MEDICINE | 1995年 / 18卷 / 06期

关键词：

OXIDIZED LDL AUTOANTIBODIES; ACUTE MYOCARDIAL INFARCTION; FREE RADICALS;

D O I：

10.1016/0891-5849(94)00216-7

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Fifteen consecutive patients (mean age 66 +/- 14, range 31-82) with an acute myocardial infarction (MI) suitable for thrombolytic therapy were included in this study. Autoantibodies against oxidized low-density lipoprotein (LDL) were determined by enzyme-linked immunosorbent assay (ELISA). Patients (n = 10) with marked elevation of the MB isoenzyme of creatinine kinase (CK-MB)-mass had significant decreases of oLDL-Ab during the acute phase, with a minimum after 8 h following the onset of thrombolytic therapy (within-group significance: p < .001; between groups: p = .01). Patients (n = 5) with CK-MB-mass values less than 70 ng/ml did not show this phenomenon. Furthermore, significant correlations existed between CK-MB-mass and oLDL-Ab after 6 and 8 h (n = 15; r = .72; p = .003) and the time of the highest CK-MB-mass values (after 12 h) and the time of the maximal decrease of oLDL-Ab (after 8 h) (r = .74; p = .003). Our observations provide further evidence for the release of free radicals and for increased lipid peroxidation during reperfusion after prolonged ischemia. The decrease of oLDL-Ab appears to be a marker for the severity of MI.

引用

页码：1087 / 1091

页数：5

共 24 条

[1]

Boyd, Gown, Wolfbauer, Chait, Direct evidence for a protein recognised by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit, Am. J. Pathol., 135, pp. 815-825, (1989)

[2]

Jurgens, Chen, Esterbauer, Mair, Ledinski, Dinges, Immunostaining of human autopsy aortas with antibodies to modified apolipoprotein B and apoprotein (a), Arterioscler. Thromb., 13, pp. 1689-1699, (1993)

[3]

Palinski, Rosenfeld, Yla-Hertuala, Gurtner, Socher, Butler, Parthasarathy, Carew, Steinberg, Witztum, Low density lipoprotein undergoes oxitative modification in vivo, Proc. Natl. Acad. Sci. USA, 86, pp. 1372-1376, (1989)

[4]

Salonen, Yla-Hertuala, Yamamoto, Butler, Korpela, Salonen, Nyyssonen, Palinski, Witztum, Autoantibody against oxidised LDL and progression of carotid atherosclerosis, Lancet, 339, pp. 883-887, (1992)

[5]

Virella, Virella, Leman, Pryor, Lopes-Virella, Anti-oxidized low-density lipoprotein antibodies in patients with coronary heart disease and normal healthy volunteers, Int. J. Clin. Lab. Res., 23, pp. 95-101, (1993)

[6]

Lesnefsky, Reduction of infarct size by cell-permeable oxygen metabolite scavengers, Free Radic. Biol. Med., 12, pp. 429-446, (1992)

[7]

Neuhaus, Feuerer, Jeep-Tebbe, Niederer, Vogt, Tebbe, Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activator, J. Am. Coll. Cardiol., 14, pp. 1566-1569, (1989)

[8]

Tatzber, Rabl, Koriska, Erhart, Puhl, Waeg, Krebs, Esterbauer, Elevated serum neopterin levels in atherosclerosis, Atherosclerosis, 89, pp. 203-208, (1991)

[9]

Winyard, Tatzber, Esterbauer, Kus, Blake, Morris, Presence of foam cells containing oxidized low density lipoprotein in the synovial membrane from patients with rheumatoid arthritis, Ann. Rheum. Dis., 52, pp. 677-680, (1993)

[10]

Schumacher, Eber, Tatzber, Kaufmann, Esterbauer, Klein, Oxidized LDL-autoantibodies in patients with coronary artery disease, Lancet, 340, (1992)

← 1 2 3 →